Promising Advances in TNBC Treatment: Sacituzum...

By HEOR Staff Writer

November 17, 2025

Sacituzumab Govitecan Shows Promise in First-Line TNBC Therapy Sacituzumab govitecan for TNBC represents a major step ...
Interchangeable Biosimilar Approval: FDA Greenlights Poherdy as First to Perjeta
HIV Therapy Advancements: Promising Results from Bictegravir/Lenacapavir Comb...
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost T...
Weight Loss: Advances in Hormone-Based Obesity Treatments
Beta-Blockers in Heart Attack Recovery: Reevaluating Their Role Based on Rece...
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Advancing Kidney Transplant Transparency Through Patient Involvement
Obesity Health Economics: Forecasting Trends and Costs in the US
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Fabhalta Kidney Treatment Shows Promise in Slowing Disease Progression for Ig...
Social Media Policy Action: Protecting Youth from Cognitive Risks